Ampio Pharmaceuticals
AMPE
#10720
Rank
S$0.36 M
Marketcap
S$0.32
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Ampio Pharmaceuticals (AMPE)

Earnings in 2023 (TTM): -S$11.54 Million

According to Ampio Pharmaceuticals's latest financial reports the company's current earnings are N/A. , an increase over its 2022 earnings that were of -S$20.85 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ampio Pharmaceuticals from 2007 to 2023

Annual earnings

Year Earnings Change
2023 -S$11.02 Million-47.14%
2022 -S$20.85 Million-4.36%
2021 -S$21.8 Million7.42%
2020 -S$20.29 Million16.62%
2019 -S$17.4 Million-140.1%
2018 S$43.37 M-165.49%
2017 -S$66.23 Million170.77%
2016 -S$24.46 Million-30.16%
2015 -S$35.03 Million-29.73%
2014 -S$49.84 Million59.2%
2013 -S$31.31 Million111.58%
2012 -S$14.8 Million-36.57%
2011 -S$23.33 Million127.2%
2010 -S$10.27 Million758.38%
2009 -S$1.2 Million3105.94%
2008 -S$0.04 Million0.79%
2007 -S$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$42.81 B-388,793.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$13.00 B-118,172.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.80 B-98,176.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$6.67 B-60,696.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Rigel Pharmaceuticals
RIGL
S$0.15 B-1,512.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-S$0.11 Billion 819.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-S$29.67 Million 169.24%๐Ÿ‡บ๐Ÿ‡ธ USA